Max Healthcare Institute shares extended their gains for the fifth consecutive session on Tuesday, rising 3 percent to Rs 1,039 per share on the NSE amid sustained buying interest in healthcare stocks.
The stock has gained around 12 percent over the past five trading sessions.
The recent buying interest comes amid expectations that healthcare companies could increase prices of other services to offset the impact of price caps on oncology drugs.
The earnings impact of the price caps is expected to ease if companies raise prices for other services, according to Deepika Muraka, healthcare sector analyst at Choice Equity Broking, Informist reported.
Earlier, companies in the sector were estimated to face a 7 percent impact on their earnings before interest, tax, depreciation and amortisation (EBITDA). However, the impact could be limited to 2 percent if they increase prices of other services to offset the losses, Muraka said.